{"version": "https://jsonfeed.org/version/1.1", "title": "Sharemaestro Newsreel: United States Medical Care Facilities news", "home_page_url": "https://sharemaestro.com/newsreel/us/healthcare/medical-care-facilities/", "feed_url": "https://sharemaestro.com/newsreel/us/healthcare/medical-care-facilities/feed.json", "description": "Latest Medical Care Facilities company headlines from United States, newest first, with source links and direct routes to company research and sentiment.", "language": "en", "items": [{"id": "source:16b3d68e8ab2dff3040c909a484f7ce822135a1fba08e48f3f45d97598dc9959", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPWFQzVzNyLVRTMHNNMElvcXJJN01HWU45c18yalNla0JCZ0M4TGlzdjdQV21ncGpnUWZ4dHRyWGs4bnN6Q1dWa09ua25wcXNoLTNvTnhXWE0teVlOcmIySkhqdnNaNjZId3Yzb0xLQkU5akE3RUdneDdNak90b3U3LWMwMUxSSElKTTBPaWNSUGJLUGVyOWVBNGxGeVNqbjBWbUlqYzZ3?oc=5", "external_url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPWFQzVzNyLVRTMHNNMElvcXJJN01HWU45c18yalNla0JCZ0M4TGlzdjdQV21ncGpnUWZ4dHRyWGs4bnN6Q1dWa09ua25wcXNoLTNvTnhXWE0teVlOcmIySkhqdnNaNjZId3Yzb0xLQkU5akE3RUdneDdNak90b3U3LWMwMUxSSElKTTBPaWNSUGJLUGVyOWVBNGxGeVNqbjBWbUlqYzZ3?oc=5", "title": "Reflecting On Healthcare Technology Stocks\u2019 Q2 Earnings: GoodRx (NASDAQ:GDRX)", "content_text": "Reflecting On Healthcare Technology Stocks\u2019 Q2 Earnings: GoodRx (NASDAQ:GDRX)", "date_published": "2026-08-14T15:49:00+00:00", "authors": [{"name": "Market source"}], "tags": ["Earnings", "HCSG"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "HCSG", "name": "Healthcare Services Group Inc", "sentiment_url": "https://sharemaestro.com/sentiment/229e85cf-95c7-4e25-b1fa-45b76db9a2cb/"}]}}, {"id": "source:5ccfbe9ca6bffb1db2efa7abe5d5960f8763e09d4d5e81f68e267193c863026c", "url": "https://www.marketbeat.com/instant-alerts/concentra-group-holdings-parent-nysecon-sets-new-1-year-high-heres-why-2026-08-14", "external_url": "https://www.marketbeat.com/instant-alerts/concentra-group-holdings-parent-nysecon-sets-new-1-year-high-heres-why-2026-08-14", "title": "Concentra Group Holdings Parent (NYSE:CON) Sets New 1-Year High - Here's Why", "content_text": "Concentra Group Holdings Parent (NYSE:CON) has reached a new 52-week high of $35.33, driven by positive analyst sentiment and strong financial performance. The company surpassed quarterly earnings expectations with an EPS of $0.52 and revenue of $606.03 million, marking a 10% year-over-year increase. Despite some insider selling, institutional investors have increased their stakes, and analysts maintain a \"Moderate Buy\" rating with a consensus target price of $37.00.", "date_published": "2026-08-14T15:12:45+00:00", "authors": [{"name": "MarketBeat"}], "tags": ["Earnings", "CON"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "CON", "name": "Concentra Group Holdings Parent, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/9fd2ca7a-02f6-4a4d-ab18-20c80ec4e515/"}]}}, {"id": "source:2c4fb12ff97bedcb851b595a51e3e121d4052a8c39e62b3eda842c7bbf3b2aac", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxPVFVRTGtJLXVndnpRWGgwUG5vVXZfRE9lMnhmM1ItR0RFclBFcWx0STN3NWFORF84QjluMFZES0tUMzVjOG00aEtjZlUybVNXbFhtaTR2U3dqeXRLRDM4QmhYMDF3amVmM1FkajNSRUpKMGtFclhrc2VXQ1J3LTFsRy1icU1ka25NQlhHcU11Q1hPb0w0YkVtYS1ReHRpV21IOTQtLWJuTDVtWUVjQzhsYzI1dXN3Z0g5V2lIUS1mV3I1eVpQM19tNmVLVm1qWm5pOFB6a0xudw?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxPVFVRTGtJLXVndnpRWGgwUG5vVXZfRE9lMnhmM1ItR0RFclBFcWx0STN3NWFORF84QjluMFZES0tUMzVjOG00aEtjZlUybVNXbFhtaTR2U3dqeXRLRDM4QmhYMDF3amVmM1FkajNSRUpKMGtFclhrc2VXQ1J3LTFsRy1icU1ka25NQlhHcU11Q1hPb0w0YkVtYS1ReHRpV21IOTQtLWJuTDVtWUVjQzhsYzI1dXN3Z0g5V2lIUS1mV3I1eVpQM19tNmVLVm1qWm5pOFB6a0xudw?oc=5", "title": "AMN Healthcare Services (NYSE:AMN) Stock Price Expected to Rise, Citizens Jmp Analyst Says", "content_text": "AMN Healthcare Services (NYSE:AMN) Stock Price Expected to Rise, Citizens Jmp Analyst Says", "date_published": "2026-08-14T13:13:53+00:00", "authors": [{"name": "MarketBeat"}], "tags": ["Analyst action", "AMN"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AMN", "name": "AMN Healthcare Services Inc", "sentiment_url": "https://sharemaestro.com/sentiment/42b6a61f-5fd4-42a5-8c96-f4bbe14ea8fc/"}]}}, {"id": "source:e4d01bbbf146aa4ec355ea8fe083db55400ff7e4df5d584bb2680379e03bd775", "url": "https://simplywall.st/stocks/us/healthcare/nyse-ci/cigna-group/news/how-cignas-dividend-hike-and-jefferies-downgrade-at-cigna-gr", "external_url": "https://simplywall.st/stocks/us/healthcare/nyse-ci/cigna-group/news/how-cignas-dividend-hike-and-jefferies-downgrade-at-cigna-gr", "title": "How Cigna\u2019s Dividend Hike And Jefferies\u2019 Downgrade At Cigna Group (CI) Has Changed Its Investment Story", "content_text": "Cigna Group recently announced a US$1.56 per share cash dividend, while Jefferies downgraded its rating to \"hold\" due to anticipated 2027 earnings headwinds. This creates a mixed investment outlook, balancing Cigna's commitment to returning capital with concerns about future earnings sustainability amid regulatory scrutiny and affordability pressures. The company's fair value is estimated at $340.92, suggesting a 23% upside, though analyst opinions on its valuation vary widely.", "date_published": "2026-08-14T10:37:26+00:00", "authors": [{"name": "Simply Wall Street"}], "tags": ["Capital return", "DVA"], "_sharemaestro": {"country": "United States", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "DVA", "name": "DaVita HealthCare Partners Inc", "sentiment_url": "https://sharemaestro.com/sentiment/bc454156-cf6a-4330-8e23-013562fc8248/"}]}}, {"id": "source:3d039369b5034a239b26c370535e933306623c02338d599301aa38a8ba68b602", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-sgry/surgery-partners/news/surgery-partners-sgry-reaffirmed-guidance-on-revenue-growth", "external_url": "https://simplywall.st/stocks/us/healthcare/nasdaq-sgry/surgery-partners/news/surgery-partners-sgry-reaffirmed-guidance-on-revenue-growth", "title": "Surgery Partners (SGRY) Reaffirmed Guidance On Revenue Growth, Is It Still A Bargain?", "content_text": "Surgery Partners (SGRY) has garnered attention after reaffirming its full-year guidance and emphasizing a focus on higher acuity procedures, despite continued net losses. The company's stock is considered 15.4% undervalued, with a fair value estimated at $17.95, driven by the migration of high-acuity surgical procedures to outpatient settings and investments in robotics. However, the narrative faces risks from higher interest costs and slower-than-planned acquisitions.", "date_published": "2026-08-14T10:30:02+00:00", "authors": [{"name": "Simply Wall Street"}], "tags": ["Deals and strategy", "SGRY"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SGRY", "name": "Surgery Partners Inc", "sentiment_url": "https://sharemaestro.com/sentiment/f22c9666-cdb5-4ff3-9539-3ca4f4fe7e65/"}]}}, {"id": "source:97beed0c04ed546c9d2a9580922e4ff569753d86f35fd800f70b65e2532024fc", "url": "https://news.google.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?oc=5", "external_url": "https://news.google.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?oc=5", "title": "DaVita (DVA) Stock Looks Discounted On Earnings While Returns Look Strong", "content_text": "DaVita (DVA) Stock Looks Discounted On Earnings While Returns Look Strong", "date_published": "2026-08-14T07:26:39+00:00", "authors": [{"name": "simplywall.st"}], "tags": ["Earnings", "DVA"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "DVA", "name": "DaVita HealthCare Partners Inc", "sentiment_url": "https://sharemaestro.com/sentiment/bc454156-cf6a-4330-8e23-013562fc8248/"}]}}, {"id": "source:0a4aa11882d687e186359af67c6c94e6e38bed9200a3b52e1440a80b17b362f0", "url": "https://news.google.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?oc=5", "external_url": "https://news.google.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?oc=5", "title": "Astrana Health (ASTH) Is Up 10.7% After Raising 2026 Guidance And Doubling Q2 Net Income - Has The Bull Case Changed?", "content_text": "Astrana Health (ASTH) Is Up 10.7% After Raising 2026 Guidance And Doubling Q2 Net Income - Has The Bull Case Changed?", "date_published": "2026-08-14T06:45:43+00:00", "authors": [{"name": "simplywall.st"}], "tags": ["Guidance", "ASTH"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ASTH", "name": "Astrana Health Inc", "sentiment_url": "https://sharemaestro.com/sentiment/7b1b50ef-1773-4669-abcb-2c7b392afed3/"}]}}, {"id": "source:f3b9eb6ca23fbbcb86f7fd25b3b4838e6df66c33c73480b3777704dacdccc242", "url": "https://www.nasdaq.com/articles/amn-healthcare-amn-q2-2026-earnings-call-transcript", "external_url": "https://www.nasdaq.com/articles/amn-healthcare-amn-q2-2026-earnings-call-transcript", "title": "AMN Healthcare (AMN) Q2 2026 Earnings Call Transcript", "content_text": "Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Randle ReecePresident and Chief Executive Officer - Caroline GraceChief Financial and Operating Officer - Brian Scott TAKEAWAYS Revenue -- $673 million, representing 2% growth compared to the prior year and finishing 6% above the high end of guidance.Nonrecurring Revenue Items -- $27 million, consisting of billing accrual true-ups from a previous labor disruption event and reserve adjustments that benefited the second quarter result.Adjusted EBITDA -- $73 million,", "date_published": "2026-08-14T04:58:39+00:00", "authors": [{"name": "nasdaq.com"}], "tags": ["Deals and strategy", "AMN"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AMN", "name": "AMN Healthcare Services Inc", "sentiment_url": "https://sharemaestro.com/sentiment/42b6a61f-5fd4-42a5-8c96-f4bbe14ea8fc/"}]}}, {"id": "source:c14d7ddb0008e91d887493334dd233851d639f15a0f910f022bdbf2444ed12be", "url": "https://news.google.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?oc=5", "external_url": "https://news.google.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?oc=5", "title": "Is Tenet Healthcare (THC) Overvalued Following Higher 2026 Adjusted EPS Guidance?", "content_text": "Is Tenet Healthcare (THC) Overvalued Following Higher 2026 Adjusted EPS Guidance?", "date_published": "2026-08-14T04:55:16+00:00", "authors": [{"name": "simplywall.st"}], "tags": ["Earnings", "HCSG"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "HCSG", "name": "Healthcare Services Group Inc", "sentiment_url": "https://sharemaestro.com/sentiment/229e85cf-95c7-4e25-b1fa-45b76db9a2cb/"}]}}, {"id": "source:338f5d8e32107a70e2609c6a9b218147957a3b183ddd7f5fe6c2eaf4a0cd5f59", "url": "https://www.nasdaq.com/articles/guardian-pharmacy-services-grdn-q2-2026-earnings-call-transcript", "external_url": "https://www.nasdaq.com/articles/guardian-pharmacy-services-grdn-q2-2026-earnings-call-transcript", "title": "Guardian Pharmacy Services (GRDN) Q2 2026 Earnings Call Transcript", "content_text": "Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Vice President, Investor Relations - Ashley StocktonPresident and Chief Executive Officer - Fred BurkeChief Operating Officer - David MorrisChief Financial Officer - Will Mudd TAKEAWAYS Revenue -- $351.8 million, up 2% year over year, reflecting headwinds from Inflation Reduction Act (IRA) pricing reductions.Adjusted EBITDA -- $29.7 million, up 19% year over year, driven by purchasing leverage and improved operating efficiency.Residents Served -- 210,000 at quarter end, up 8% year over year, due to org", "date_published": "2026-08-13T23:44:25+00:00", "authors": [{"name": "nasdaq.com"}], "tags": ["Earnings", "GRDN"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "GRDN", "name": "Guardian Pharmacy Services, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/ab6794dc-f722-48cf-b38a-1ff4be20db65/"}]}}, {"id": "source:a8d459ba3ba614bd4bebb6b337cacc7673c89aa65c0230f84f16c80d62bc4513", "url": "https://www.stocktitan.net/sec-filings/ENSG/form-4-ensign-group-inc-insider-trading-activity-4d2dd25baedb.html", "external_url": "https://www.stocktitan.net/sec-filings/ENSG/form-4-ensign-group-inc-insider-trading-activity-4d2dd25baedb.html", "title": "Ensign Group (ENSG) President & COO gifts 2,500 shares, retains 65,970", "content_text": "Ensign Group (ENSG) President and COO Burton Spencer gifted 2,500 shares of common stock on August 11, 2026, as reported in a Form 4 filing. This transaction was executed under a Rule 10b5-1 trading plan adopted on February 9, 2026. Following this gift, Spencer directly holds 65,970 shares of ENSG common stock.", "date_published": "2026-08-13T23:41:39+00:00", "authors": [{"name": "Stock Titan"}], "tags": ["Market update", "ENSG"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ENSG", "name": "The Ensign Group Inc", "sentiment_url": "https://sharemaestro.com/sentiment/7b9ae34d-b757-4991-9b6a-d669db9fd073/"}]}}, {"id": "watch:1f64d62a-e30d-46d8-b59a-81805dd247bb", "url": "https://sharemaestro.com/market-watch/davita-dva-steep-weekly-drop-heavy-turnover/", "external_url": null, "title": "DaVita HealthCare Partners Inc (DVA) suffers steep weekly drop on heavy turnover", "content_text": "The dialysis-center operator\u2019s 52-week weekly chart now shows short-term damage outweighing a still-active trend reading.", "date_published": "2026-08-13T23:29:24.494679+00:00", "authors": [{"name": "Sharemaestro Market Watch"}], "tags": ["Volume surge", "DVA"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "DVA", "name": "DaVita HealthCare Partners Inc", "sentiment_url": "https://sharemaestro.com/sentiment/bc454156-cf6a-4330-8e23-013562fc8248/"}]}}, {"id": "source:3fc70592ed71b157fcac35622da8fdd5d991acaa75ff45b1e98f25abf1e81ac7", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQSnFIRzZwdDBtdGptVm9VZkVMU1BrZUlrVkJWTUxNZzM2SGFtcWtBVGIzX29BSEVOSnNka25va2lqMFlMNEpJVnNLRmhaZG1VZGlNam5aNU1qc2FjMXVJc2xyY3lYbWlCU0FkYXRScmlpOUJ1WHZyUTN1T00xcGV1Mk8zQlB2RTlCX0VmQ1V5ZzRLdk5HVndiaWJBeDlEa0xjRS04X0VjOXhNdnNvMHkycDZhc0JHRUx3cm1QZXRUNkFOX19IeTd6bg?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQSnFIRzZwdDBtdGptVm9VZkVMU1BrZUlrVkJWTUxNZzM2SGFtcWtBVGIzX29BSEVOSnNka25va2lqMFlMNEpJVnNLRmhaZG1VZGlNam5aNU1qc2FjMXVJc2xyY3lYbWlCU0FkYXRScmlpOUJ1WHZyUTN1T00xcGV1Mk8zQlB2RTlCX0VmQ1V5ZzRLdk5HVndiaWJBeDlEa0xjRS04X0VjOXhNdnNvMHkycDZhc0JHRUx3cm1QZXRUNkFOX19IeTd6bg?oc=5", "title": "Nutex Health (NUTX) Q2 2026 Earnings Call Transcript", "content_text": "Nutex Health (NUTX) Q2 2026 Earnings Call Transcript", "date_published": "2026-08-13T23:28:12+00:00", "authors": [{"name": "The Globe and Mail"}], "tags": ["Earnings", "NUTX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "NUTX", "name": "Nutex Health Inc", "sentiment_url": "https://sharemaestro.com/sentiment/e5ddd69b-3c28-4c0d-8247-541f77cd2d69/"}]}}, {"id": "source:d4dc53a081444be13f23ed69845ef3beab900b962b4fcff02a0d9e926c19462e", "url": "https://kalkinemedia.com/us/news/announcements/addus-homecare-appoints-w-bradley-bickham-as-interim-coo-following-heather-dixons-exit", "external_url": "https://kalkinemedia.com/us/news/announcements/addus-homecare-appoints-w-bradley-bickham-as-interim-coo-following-heather-dixons-exit", "title": "Addus HomeCare Appoints W. Bradley Bickham as Interim COO Following Heather Dixon's Exit", "content_text": "Addus HomeCare Corporation announced the departure of President and COO Heather Dixon, effective August 7, 2026. W. Bradley Bickham has been appointed as interim Chief Operating Officer, also effective August 7, 2026. Bickham, who previously served as President and COO, will have an annual base salary of $622,000 and his employment agreement extends through July 31, 2027.", "date_published": "2026-08-13T22:40:07+00:00", "authors": [{"name": "Kalkine Media"}], "tags": ["Market update", "ADUS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ADUS", "name": "Addus HomeCare Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/cd4cb881-0e00-46b3-b858-92da1467c445/"}]}}, {"id": "source:d24f03e171dcc6919f537e9491918e8c8f9a33221c26e24cf2891fd1bebba413", "url": "https://finance.yahoo.com/healthcare/articles/could-hca-healthcare-inc-hca-221733771.html", "external_url": "https://finance.yahoo.com/healthcare/articles/could-hca-healthcare-inc-hca-221733771.html", "title": "Could HCA Healthcare, Inc. (HCA) Stock Rebound After Guidance Cuts and Payer Pressure?", "content_text": "HCA Healthcare, Inc. (NYSE:HCA) reported its second-quarter 2026 financial results on July 24, confirming the figures previewed earlier in the month. While top-line growth remained healthy, a visible deterioration in payer mix and a revision to full-year profitability guidance triggered immediate target cuts across Wall Street. In its Q2 results, HCA Healthcare, Inc. reported that revenue increased 8.7% year-over-year to $20.23 billion from $18.61 billion in Q2 2025. The firm's net income attributable to the company rose 2.8% to $1.69 billion, while diluted EPS increased 11.6% to $7.62 (or $7.", "date_published": "2026-08-13T22:17:33+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "HCA"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "HCA", "name": "HCA Healthcare, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/7a27b2ce-6925-41f4-8b94-e888c7172842/"}]}}, {"id": "source:8c65773d939b403752ecde6c786728cc1d5de75c39e8e8750bf4b495c54dee62", "url": "https://www.marketwatch.com/data-news/davita-inc-stock-outperforms-competitors-despite-losses-on-the-day-3f8cbce8-061ed0c75a3a?mod=goog_fin_scmw", "external_url": "https://www.marketwatch.com/data-news/davita-inc-stock-outperforms-competitors-despite-losses-on-the-day-3f8cbce8-061ed0c75a3a?mod=goog_fin_scmw", "title": "DaVita Inc. stock outperforms competitors despite losses on the day", "content_text": "Despite a daily loss of 1.28% for its stock, DaVita Inc. (DVA) outperformed the broader market, which saw the S&P 500 and Dow Jones Industrial Average rise. DaVita's shares closed at $179.17, still significantly below its 52-week high achieved earlier in August.", "date_published": "2026-08-13T21:37:39+00:00", "authors": [{"name": "MarketWatch"}], "tags": ["Earnings", "DVA"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "DVA", "name": "DaVita HealthCare Partners Inc", "sentiment_url": "https://sharemaestro.com/sentiment/bc454156-cf6a-4330-8e23-013562fc8248/"}]}}, {"id": "source:71b9af1bb6692cd85376a2aece7afac631127e02992a50223b2ac7800d27954a", "url": "https://ca.investing.com/news/stock-market-news/form-8k-encompass-health-corp-for-13-august-93CH-4799722", "external_url": "https://ca.investing.com/news/stock-market-news/form-8k-encompass-health-corp-for-13-august-93CH-4799722", "title": "Form 8K Encompass Health Corp For: 13 August By Investing.com", "content_text": "This article reports on the filing of a Form 8K by Encompass Health Corp on August 13. The brief notice from Investing.com indicates this as a stock market event without providing further details on the content of the filing.", "date_published": "2026-08-13T20:40:30+00:00", "authors": [{"name": "Investing.com Canada"}], "tags": ["Market update", "EHC"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "EHC", "name": "Encompass Health Corp", "sentiment_url": "https://sharemaestro.com/sentiment/9cf91720-3ed7-4e95-a55d-a43e5bd77e55/"}]}}, {"id": "source:624231ee5c94c56e2a45bbba29768fffdcd8a18b2be86e9111d4eb9954610763", "url": "https://m.investing.com/news/sec-filings/encompass-health-completes-100-million-senior-notes-offering-to-repay-debt-93CH-4859245?ampMode=1", "external_url": "https://m.investing.com/news/sec-filings/encompass-health-completes-100-million-senior-notes-offering-to-repay-debt-93CH-4859245?ampMode=1", "title": "Encompass Health completes $100 million senior notes offering to repay debt", "content_text": "Encompass Health Corporation has successfully issued $100 million in 5.875% Senior Notes due 2034, generating net proceeds of approximately $96.9 million. These proceeds, along with existing cash, were used to repay a portion of its revolving credit facility. The company recently reported strong second-quarter 2026 results, exceeding Wall Street expectations for both EPS and revenue, and has raised its financial outlook.", "date_published": "2026-08-13T20:40:29+00:00", "authors": [{"name": "Investing.com"}], "tags": ["Earnings", "EHC"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "EHC", "name": "Encompass Health Corp", "sentiment_url": "https://sharemaestro.com/sentiment/9cf91720-3ed7-4e95-a55d-a43e5bd77e55/"}]}}, {"id": "source:804f31e4cae911a49c1087001a4b19d1cf405fe7ee959e00b0a6d75b3cf9f957", "url": "https://www.tradingview.com/news/tradingview:9219ec818cf3a:0-encompass-health-issues-100m-of-5-875-senior-notes-due-2034-nets-96-9m", "external_url": "https://www.tradingview.com/news/tradingview:9219ec818cf3a:0-encompass-health-issues-100m-of-5-875-senior-notes-due-2034-nets-96-9m", "title": "Encompass Health issues $100M of 5.875% senior notes due 2034, nets ~$96.9M", "content_text": "Encompass Health (EHC) has completed a private issuance of $100 million in 5.875% Senior Notes due 2034, generating approximately $96.9 million after discounts and expenses. The proceeds, along with cash on hand, were utilized to reduce short-term borrowings by repaying a portion of the company's revolving credit facility. These new notes share identical terms with existing 2034 notes and were sold to qualified institutional buyers and non-U.S. persons.", "date_published": "2026-08-13T20:40:29+00:00", "authors": [{"name": "TradingView"}], "tags": ["Earnings", "EHC"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "EHC", "name": "Encompass Health Corp", "sentiment_url": "https://sharemaestro.com/sentiment/9cf91720-3ed7-4e95-a55d-a43e5bd77e55/"}]}}, {"id": "source:747bdb7b81e3fa069045f0e3ab4f9456de38d9d661d3380dcbe691564f7eb655", "url": "https://www.stocktitan.net/sec-filings/ADUS/8-k-addus-home-care-corp-reports-material-event-14941769576c.html", "external_url": "https://www.stocktitan.net/sec-filings/ADUS/8-k-addus-home-care-corp-reports-material-event-14941769576c.html", "title": "Addus HomeCare (ADUS) COO Heather Dixon exits as veteran leader Brad Bickham returns", "content_text": "Addus HomeCare Corporation announced that President and COO Heather Dixon left the company on August 7, 2026. Veteran leader W. Bradley Bickham, who previously served as President and COO, has been appointed as interim Chief Operating Officer. Bickham's employment agreement will run through July 31, 2027, with an annualized base salary of $622,000.", "date_published": "2026-08-13T20:40:07+00:00", "authors": [{"name": "Stock Titan"}], "tags": ["Earnings", "ADUS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ADUS", "name": "Addus HomeCare Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/cd4cb881-0e00-46b3-b858-92da1467c445/"}]}}, {"id": "source:ea45b503f1352dfd5e624336da1c55de7b043fdf523709d34be9877d9c68a083", "url": "https://www.stocktitan.net/sec-filings/AMN/schedule-13g-amn-healthcare-services-inc-passive-investment-disclosur-c32a49e42827.html", "external_url": "https://www.stocktitan.net/sec-filings/AMN/schedule-13g-amn-healthcare-services-inc-passive-investment-disclosur-c32a49e42827.html", "title": "Morgan Stanley (AMN) discloses 2.08M-share beneficial stake in AMN Healthcare", "content_text": "Morgan Stanley has disclosed a 5.4% passive ownership stake in AMN Healthcare Services, Inc., amounting to 2,076,006 shares of common stock as of June 30, 2026. The filing, a Schedule 13G, indicates that Morgan Stanley has shared voting power over 2,075,030 shares and shared dispositive power over all 2,076,006 shares, with no sole voting or dispositive power. This disclosure applies only to specific Morgan Stanley operating units, as detailed in the SEC filing.", "date_published": "2026-08-13T20:11:52+00:00", "authors": [{"name": "Stock Titan"}], "tags": ["Deals and strategy", "AMN"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AMN", "name": "AMN Healthcare Services Inc", "sentiment_url": "https://sharemaestro.com/sentiment/42b6a61f-5fd4-42a5-8c96-f4bbe14ea8fc/"}]}}, {"id": "source:0b0fb9490ab43a14a6f259c15ca65616328960edddf47dcbe17e6d04df9ccb3e", "url": "https://www.tradingview.com/news/zacks:dade712b2094b:0-here-s-why-pediatrix-medical-can-be-a-smart-addition-to-your-portfolio", "external_url": "https://www.tradingview.com/news/zacks:dade712b2094b:0-here-s-why-pediatrix-medical-can-be-a-smart-addition-to-your-portfolio", "title": "Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio", "content_text": "Pediatrix Medical (MD) is presented as a smart investment due to its strong year-to-date performance, strategic acquisitions, and robust financial metrics like an 11.6% return on invested capital. The company benefits from improved cash collections, a favorable payer mix, and higher patient acuity in neonatology, with further growth expected from expanding telehybrid care and OB hospitalist services. Despite a high debt load, Pediatrix Medical carries a Zacks Rank #2 (Buy) and is projected to see significant earnings and revenue growth in 2026.", "date_published": "2026-08-13T16:13:06+00:00", "authors": [{"name": "TradingView"}], "tags": ["Deals and strategy", "MD"], "_sharemaestro": {"country": "United States", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "MD", "name": "Mednax Inc", "sentiment_url": "https://sharemaestro.com/sentiment/dde769e7-6501-4809-8099-0e9ba18c0c14/"}]}}, {"id": "source:2d987f7154cf20500be4058c028d53452196c7f58fab10dbc5b761901cf07d3e", "url": "https://finance.yahoo.com/markets/stocks/articles/lifestance-health-group-lfst-3-160002298.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/lifestance-health-group-lfst-3-160002298.html", "title": "LifeStance Health Group (LFST) Is Up 3.44% in One Week: What You Should Know", "content_text": "Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the \"long context,\" investors will essentially be \"buying high, but hoping to sell even higher.\" And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades. Even though momentum is a popular stock characteristic, it can be tough to define. Debate s", "date_published": "2026-08-13T16:00:02+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "LFST"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "LFST", "name": "Lifestance Health Group Inc", "sentiment_url": "https://sharemaestro.com/sentiment/75d27d2e-5c7a-4267-a6b8-98f5d79fed41/"}]}}, {"id": "source:ac0ebbd41676afc088b02a10e732fbb4d4e125dd9569dbdee1965bc5ac158a3a", "url": "https://www.ad-hoc-news.de/boerse/news/corporate-news/fresenius-medical-care-stock-holds-steady-near-24-as-investors-digest/69946118", "external_url": "https://www.ad-hoc-news.de/boerse/news/corporate-news/fresenius-medical-care-stock-holds-steady-near-24-as-investors-digest/69946118", "title": "Fresenius Medical Care stock holds steady near $24 as investors digest latest capital market update", "content_text": "Fresenius Medical Care stock is trading near $24, with a slight decline of 0.67% on the NYSE and 0.28% in Europe, as investors analyze the company's latest capital market update. This update details recent share repurchases and trading activity, suggesting a strategy to optimize capital structure. The company, a global provider of dialysis services and products, shows modest daily fluctuations rather than a significant sell-off or rally.", "date_published": "2026-08-13T14:39:54+00:00", "authors": [{"name": "AD HOC NEWS"}], "tags": ["Earnings", "FMS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "FMS", "name": "Fresenius Medical Care Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/27e2f7b1-dd48-4aa0-9487-0537c505e5d1/"}]}}, {"id": "source:a3af7b0f46cc4b11a3e6c3cceaea4dc1b48a6a6745868db1809d13b080acfcef", "url": "https://za.investing.com/news/stock-market-news/form-8k-universal-health-services-for-13-august-93CH-4427478", "external_url": "https://za.investing.com/news/stock-market-news/form-8k-universal-health-services-for-13-august-93CH-4427478", "title": "Form 8K Universal Health Services For: 13 August By Investing.com", "content_text": "This article reports on the filing of a Form 8K by Universal Health Services, dated August 13. The brief notice provides a direct reference to the filing and includes the stock symbol UHS. The content appears to be a standard financial news alert, providing minimal detail beyond the event itself.", "date_published": "2026-08-13T14:39:39+00:00", "authors": [{"name": "Investing.com South Africa"}], "tags": ["Market update", "UHS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "UHS", "name": "Universal Health Services Inc", "sentiment_url": "https://sharemaestro.com/sentiment/d32e8a62-0e64-42b3-be06-2c522c6c4f41/"}]}}, {"id": "source:f72dfa85c5801a2abf06a3963921771095e9313b30995801c04e979c73da3ecf", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQWVBWa0ctaWNjWU4tZFItakF1RWx6eHlMVXcwaENoOE00TDVBQW9HYmd0ekpVTzBVZ0FYM3VtckNYMkFyQ1ZLOEJfT2hBcHNtMEEyZkg2X0JOZUNURVFHektSaHZtTkRuTWVjamlkd2xaWEpKY2MtUkFJQVZtQzduZDhkUWgyWVctMGVSZmx0d1BOOEQzQVM2b0NqS0VZeTN1RDR3X2lkYmFnQ1JwdWJKMFo4U1plVktTbkdlRmFIZHRKSGtqdVlVYWM3OW53MVE5LWV2Ug?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQWVBWa0ctaWNjWU4tZFItakF1RWx6eHlMVXcwaENoOE00TDVBQW9HYmd0ekpVTzBVZ0FYM3VtckNYMkFyQ1ZLOEJfT2hBcHNtMEEyZkg2X0JOZUNURVFHektSaHZtTkRuTWVjamlkd2xaWEpKY2MtUkFJQVZtQzduZDhkUWgyWVctMGVSZmx0d1BOOEQzQVM2b0NqS0VZeTN1RDR3X2lkYmFnQ1JwdWJKMFo4U1plVktTbkdlRmFIZHRKSGtqdVlVYWM3OW53MVE5LWV2Ug?oc=5", "title": "Wall Street Analysts See a 25.73% Upside in PACS Group, Inc. (PACS): Can the Stock Really Move This High?", "content_text": "PACS Group, Inc. (PACS) closed the last trading session at $45.47, gaining 1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $57.17 indicates a 25.7% upside potential. The average comprises six short-term price targets ranging from a low of $47.00 to a high of $62.00, with a standard deviation of $5.34. While the lowest estimate indicates an increase of 3.4% from the current price level, the most optimistic estimate points to a 36.4% upside. More than the range, one ", "date_published": "2026-08-13T13:54:16+00:00", "authors": [{"name": "Zacks Investment Research"}], "tags": ["Earnings", "PACS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PACS", "name": "PACS Group, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/5a66909f-3df1-412f-afd2-d09859b2112d/"}]}}, {"id": "source:5a91791fb202311547b14eb2c14ac72a03024f78c16378bdcdd5939ab22d31e2", "url": "https://www.investing.com/news/transcripts/earnings-call-transcript-park-dental-partners-tops-q2-2026-eps-estimates-93CH-4858324", "external_url": "https://www.investing.com/news/transcripts/earnings-call-transcript-park-dental-partners-tops-q2-2026-eps-estimates-93CH-4858324", "title": "Earnings call transcript: Park Dental Partners tops Q2 2026 EPS estimates", "content_text": "Park Dental Partners announced strong Q2 2026 results, with adjusted EPS of $0.66 significantly beating analyst estimates of $0.38 and revenue increasing 5.1% to $66.2 million. The company's stock rose sharply after the announcement, nearing its 52-week high. Park Dental Partners also highlighted its strategic expansion, including the planned acquisition of Village Family Dental, which will add 48 doctors and 12 locations in North Carolina.", "date_published": "2026-08-13T13:40:42+00:00", "authors": [{"name": "Investing.com"}], "tags": ["Deals and strategy", "PARK"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PARK", "name": "Park Dental Partners, Inc. Common Stock", "sentiment_url": "https://sharemaestro.com/sentiment/d1740ad7-4a5b-4b11-a839-a7b6432c3736/"}]}}, {"id": "source:d53ef0be379a9a724a8c9d2727f3876a109524b57d90c25b9e86d0ae04bfe6a5", "url": "https://finance.yahoo.com/markets/stocks/articles/1-momentum-stock-long-term-133300081.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/1-momentum-stock-long-term-133300081.html", "title": "1 Momentum Stock for Long-Term Investors and 2 We Brush Off", "content_text": "1 Momentum Stock for Long-Term Investors and 2 We Brush Off The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds. However, not all companies with momentum are long-term winners, and many investors have lost money by following short-term trends. All that said, here is one stock with the fundamentals to back up its performance and two best left ignored. Two Stocks to Sell: Chemed (CHE) One-Month Return: +11.6% With a unique business mod", "date_published": "2026-08-13T13:33:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "CHE"], "_sharemaestro": {"country": "United States", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "CHE", "name": "Chemed Corp", "sentiment_url": "https://sharemaestro.com/sentiment/38be94d1-240b-41ff-a939-1d374b390ed4/"}]}}, {"id": "source:b4fe3822d6be567486c18d9e6bc6025c399c3daf88648328800d12d9b31c30b6", "url": "https://finance.yahoo.com/markets/stocks/articles/zacks-com-featured-highlights-lifestance-131100892.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/zacks-com-featured-highlights-lifestance-131100892.html", "title": "Zacks.com featured highlights include LifeStance Health, Tutor Perini, Valero Energy, SharkNinja and Lumentum", "content_text": "For Immediate Release Chicago, IL \u2013 August 13, 2026 \u2013 Stocks in this week's article are LifeStance Health Group LFST, Tutor Perini TPC, Valero Energy VLO, SharkNinja, Inc. SN and Lumentum LITE. 5 Low-Leverage Stocks to Buy as High Oil Prices Shake Investor Confidence Major U.S. stock indices ended lower on Aug. 12, 2026, as investor sentiment was weighed down by escalating U.S.-Iran tensions and dimming prospects for the reopening of the Strait of Hormuz. A surge in crude oil prices, combined with underperformance across key technology stocks, further pressured the broader market. In an enviro", "date_published": "2026-08-13T13:11:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "LFST"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "LFST", "name": "Lifestance Health Group Inc", "sentiment_url": "https://sharemaestro.com/sentiment/75d27d2e-5c7a-4267-a6b8-98f5d79fed41/"}]}}, {"id": "source:2ec2a0be5371cfc4edd4583ada9413d701f8f6f9afa6a017ecc9050ce6d0f8e7", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNTTRmVUx6ZzdrUUFwS0tvTGVvbGg5dU1nczBmZXotYldNVGFDMkM2Vi1JOWlnWDVTSWNubFh0Y3VxSW1xalItak9xMXZEeXJ1Q0k1a250T2d4aVhXSWJfeFAtMWxOMFloa2wzaHB5Z3dYVmhxbGh5TFR5RzJpOVZ6c0l0MHJ0YkVPVzMtSlBveGoyWk1fUWlWMlREWC1zNV85ajhxblNuQzE0LVBVNlE?oc=5", "external_url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNTTRmVUx6ZzdrUUFwS0tvTGVvbGg5dU1nczBmZXotYldNVGFDMkM2Vi1JOWlnWDVTSWNubFh0Y3VxSW1xalItak9xMXZEeXJ1Q0k1a250T2d4aVhXSWJfeFAtMWxOMFloa2wzaHB5Z3dYVmhxbGh5TFR5RzJpOVZ6c0l0MHJ0YkVPVzMtSlBveGoyWk1fUWlWMlREWC1zNV85ajhxblNuQzE0LVBVNlE?oc=5", "title": "AMN Healthcare Services: Strong Secular Growth Propels Earnings (NYSE:AMN)", "content_text": "AMN Healthcare Services: Strong Secular Growth Propels Earnings (NYSE:AMN)", "date_published": "2026-08-13T12:54:18+00:00", "authors": [{"name": "Seeking Alpha"}], "tags": ["Earnings", "AMN"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AMN", "name": "AMN Healthcare Services Inc", "sentiment_url": "https://sharemaestro.com/sentiment/42b6a61f-5fd4-42a5-8c96-f4bbe14ea8fc/"}]}}, {"id": "source:af9cec0d9913ff321afe5411721641b8a735d75cba7e6f4a4715951b20716c57", "url": "https://finance.yahoo.com/markets/options/articles/implied-volatility-surging-ardent-health-124600265.html", "external_url": "https://finance.yahoo.com/markets/options/articles/implied-volatility-surging-ardent-health-124600265.html", "title": "Implied Volatility Surging for Ardent Health Stock Options", "content_text": "Investors in Ardent Health, Inc. ARDT need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 15, 2027 $25 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. Ho", "date_published": "2026-08-13T12:46:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "ARDT"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ARDT", "name": "Ardent Health Partners, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/a89e0bd4-81c8-4ac3-82ca-3969510d4d1e/"}]}}, {"id": "source:f640d0b51a720663cbaa876d009866519b80684626e45107f075662e54379073", "url": "https://www.marketscreener.com/news/bofa-securities-adjusts-price-target-on-concentra-group-to-40-from-36-ce7859d9df8cf226", "external_url": "https://www.marketscreener.com/news/bofa-securities-adjusts-price-target-on-concentra-group-to-40-from-36-ce7859d9df8cf226", "title": "BofA Securities Adjusts Price Target on Concentra Group to $40 From $36", "content_text": "BofA Securities has raised its price target for Concentra Group Holdings Parent, Inc. (CON) to $40 from $36, as reported by MT Newswires.", "date_published": "2026-08-13T12:42:47+00:00", "authors": [{"name": "www.marketscreener.com"}], "tags": ["Analyst action", "CON"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "CON", "name": "Concentra Group Holdings Parent, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/9fd2ca7a-02f6-4a4d-ab18-20c80ec4e515/"}]}}, {"id": "source:7d0a36db19d91a93c4a6e58592154a1d660b05f694b1336872a8abd96a62327a", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPaXZkLUtnZFVMby1UYTBuR3d5UWd4LWhuTEJycnVSSnFkVVpzb1Z0Qmo5dlpmMXd4NzZHWHYwLXJxcnZkeUhIQy10UE9fMy1qWGZHVjA3NVFYNm1jZVlDbTl0OGNzQkMyVUJIdWxfanc2OWZwdWYxdUV5dkYzMGlOd0RXcDlpbnJHaE1XbkxzS0RrN1ZHTXViOEhnT0VHZFFKbXVySS1weDZxdVpocnh6UU5OUWYzb0pzMXg2Z2JJWWpPYmozRElHOXFwV3NWRzV2a3hsTVNR0gHbAUFVX3lxTE9WY00wcllOMGpPOUVhc2tuZHBQRlF3WDJOZEVKSmdQa0RRUzdYRnUzdkNFX2IxclQ4TndaRWtKS000NTBJUWVPWXlyZTFzZENMckZhTFRmWkdWc3JaTmJaRElTN3pDbXpsNmhhYUVEM09XekN1Y3V5MnlSN1Z6d3RGVGJsaHR1dnUxcklfcjRxOTN6b0tfYUp2VTRrdnp0QUd6NENxQTRWZkNXVGNOVXQxSDJ6UkxTR0xfWkxjZGxuOXRJdXk1TmNxLTJIY0NmMmxiRUhONHViTnp0bw?oc=5", "external_url": "https://news.google.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?oc=5", "title": "US$18.00 - That's What Analysts Think P3 Health Partners Inc. (NASDAQ:PIII) Is Worth After These Results", "content_text": "US$18.00 - That's What Analysts Think P3 Health Partners Inc. (NASDAQ:PIII) Is Worth After These Results", "date_published": "2026-08-13T12:30:16+00:00", "authors": [{"name": "simplywall.st"}], "tags": ["Earnings", "PIII"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PIII", "name": "P3 Health Partners Inc", "sentiment_url": "https://sharemaestro.com/sentiment/08a161f9-98d8-4c6d-9896-d03ee812906f/"}]}}, {"id": "source:755a43101773b6fafb77446e42ce6a9d071e71d6016eee3bb70f072807d55bc9", "url": "https://m.investing.com/news/sec-filings/sonida-senior-living-enters-380-million-term-loan-agreement-with-ally-bank-93CH-4857915?ampMode=1", "external_url": "https://m.investing.com/news/sec-filings/sonida-senior-living-enters-380-million-term-loan-agreement-with-ally-bank-93CH-4857915?ampMode=1", "title": "Sonida Senior Living enters $380 million term loan agreement with Ally Bank", "content_text": "Sonida Senior Living (NYSE:SNDA) announced a new $380 million senior secured term loan agreement with Ally Bank, signed on August 7, 2026. This new financing amends an existing agreement and provides an initial advance of $372.5 million, secured by 28 communities. The loan has a five-year maturity with optional extensions and carries a variable interest rate based on SOFR plus 1.85%.", "date_published": "2026-08-13T12:09:54+00:00", "authors": [{"name": "Investing.com"}], "tags": ["Deals and strategy", "SNDA"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SNDA", "name": "Sonida Senior Living Inc", "sentiment_url": "https://sharemaestro.com/sentiment/079d3408-0745-4cd7-919e-16f4e909130f/"}]}}, {"id": "source:15e0a3acaaa65228fabb831d0b84ad68ab5f8283d9c2240fe97647d22f077477", "url": "https://www.marketscreener.com/news/avah-aveanna-healthcare-expects-2026-revenue-higher-than-2-68b-vs-factset-est-of-2-63b-ce7859d9df89f020", "external_url": "https://www.marketscreener.com/news/avah-aveanna-healthcare-expects-2026-revenue-higher-than-2-68b-vs-factset-est-of-2-63b-ce7859d9df89f020", "title": "(AVAH) Aveanna Healthcare Expects 2026 Revenue Higher Than $2.68B, vs. FactSet Est of $2.63B", "content_text": "Aveanna Healthcare Holdings Inc. (AVAH) anticipates its 2026 revenue to exceed $2.68 billion, surpassing FactSet's estimate of $2.63 billion. This announcement comes alongside the release of their fiscal Q2 adjusted earnings and revenue, both of which have risen. The company also reported Q2 revenue of $670.5 million and adjusted EPS of $0.22, both beating FactSet estimates.", "date_published": "2026-08-13T11:43:27+00:00", "authors": [{"name": "marketscreener.com"}], "tags": ["Earnings", "AVAH"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AVAH", "name": "Aveanna Healthcare Holdings Inc", "sentiment_url": "https://sharemaestro.com/sentiment/985bd0b1-b16d-4b25-b5f0-9f1b5681f7f6/"}]}}, {"id": "source:1dcc9503f595077d07b4faa7cd8a3c7b094e322fd96c65b95e0d63dc1978d5c7", "url": "https://www.globenewswire.com/news-release/2026/08/13/3344373/0/en/aveanna-healthcare-holdings-announces-second-quarter-financial-results-and-revised-2026-guidance.html", "external_url": "https://www.globenewswire.com/news-release/2026/08/13/3344373/0/en/aveanna-healthcare-holdings-announces-second-quarter-financial-results-and-revised-2026-guidance.html", "title": "Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2026 Guidance", "content_text": "Aveanna Healthcare Holdings (NASDAQ: AVAH) reported strong second-quarter 2026 financial results, with revenue increasing by 13.7% to $670.5 million and net income rising to $40.3 million. The company also increased its full-year 2026 guidance, projecting revenue greater than $2.68 billion and Adjusted EBITDA greater than $365 million, citing strong organic growth across all business segments and effective strategic initiatives.", "date_published": "2026-08-13T10:41:27+00:00", "authors": [{"name": "GlobeNewswire"}], "tags": ["Earnings", "AVAH"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AVAH", "name": "Aveanna Healthcare Holdings Inc", "sentiment_url": "https://sharemaestro.com/sentiment/985bd0b1-b16d-4b25-b5f0-9f1b5681f7f6/"}]}}, {"id": "source:cc389073a6046939d952a59e6ec702019c2cd6d0e7537d409941cabf844e6eb1", "url": "https://www.quiverquant.com/news/Aveanna+AVAH+Q2+Revenue+Rises+13.7%25+to+%24670.5+Million", "external_url": "https://www.quiverquant.com/news/Aveanna+AVAH+Q2+Revenue+Rises+13.7%25+to+%24670.5+Million", "title": "Aveanna AVAH Q2 Revenue Rises 13.7% to $670.5 Million", "content_text": "Aveanna Healthcare Holdings (AVAH) reported a 13.7% increase in second-quarter 2026 revenue, reaching $670.5 million, with net income rising to $40.3 million. The company also raised its full-year 2026 revenue guidance to over $2.68 billion and adjusted EBITDA guidance to over $365 million. Insider trading data shows significant selling activity, while institutional investors have both added and decreased their positions in AVAH stock.", "date_published": "2026-08-13T10:41:27+00:00", "authors": [{"name": "Quiver Quantitative"}], "tags": ["Earnings", "AVAH"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AVAH", "name": "Aveanna Healthcare Holdings Inc", "sentiment_url": "https://sharemaestro.com/sentiment/985bd0b1-b16d-4b25-b5f0-9f1b5681f7f6/"}]}}, {"id": "source:1d2db93eb6e8031f830cc9ba6e171924742d6247befd431cc470b42446eddc82", "url": "https://uk.finance.yahoo.com/research/reports/ARGUS_3796_QuantitativeReport_1786492800000", "external_url": "https://uk.finance.yahoo.com/research/reports/ARGUS_3796_QuantitativeReport_1786492800000", "title": "DaVita Inc. (DVA) Stock forecasts", "content_text": "Argus has lowered its target price for DaVita Inc. (DVA) to $187.00. DaVita is identified as the largest provider of dialysis services in the United States, holding approximately 35% market share by clinics. The current price of DVA stock is $181.41.", "date_published": "2026-08-13T10:37:46+00:00", "authors": [{"name": "Market source"}], "tags": ["Earnings", "DVA"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "DVA", "name": "DaVita HealthCare Partners Inc", "sentiment_url": "https://sharemaestro.com/sentiment/bc454156-cf6a-4330-8e23-013562fc8248/"}]}}, {"id": "source:78a1c410844dab14bb4d45fda4cda2b802b9b4fade1b01eba3bb1d216197d30f", "url": "https://simplywall.st/stocks/us/healthcare/nyse-bkd/brookdale-senior-living/news/why-brookdale-senior-living-bkd-is-down-100-after-swinging-t/amp", "external_url": "https://simplywall.st/stocks/us/healthcare/nyse-bkd/brookdale-senior-living/news/why-brookdale-senior-living-bkd-is-down-100-after-swinging-t/amp", "title": "Why Brookdale Senior Living (BKD) Is Down 10.0% After Swinging To Q2 Profit On Lower Revenue", "content_text": "Brookdale Senior Living (BKD) reported a swing to net profit in Q2 2026 despite lower revenue, with earnings of US$0.10 per share. The company reaffirmed its 2026 adjusted EBITDA outlook and strengthened its balance sheet through refinancing, aiming for sustained profitability despite ongoing revenue pressures and capital needs. The stock dropped 10.0% following the announcement.", "date_published": "2026-08-13T09:43:42+00:00", "authors": [{"name": "Simply Wall Street"}], "tags": ["Earnings", "BKD"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "BKD", "name": "Brookdale Senior Living Inc", "sentiment_url": "https://sharemaestro.com/sentiment/650787e2-24de-447b-a593-f86524c54d39/"}]}}, {"id": "source:ac9b0c07aeb8c363d164c659fcd67de7629cd60eb68883b5a63d213443d3c92b", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/should-va-backed-pivot-trial-on-comp360-in-veterans-require/amp", "external_url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/should-va-backed-pivot-trial-on-comp360-in-veterans-require/amp", "title": "Should VA-Backed PIVOT Trial on COMP360 in Veterans Require Action From COMPASS Pathways (CMPS) Investors?", "content_text": "COMPASS Pathways announced a collaboration with the U.S. Department of Veterans Affairs on the PIVOT trial, evaluating COMP360 psilocybin for treatment-resistant depression in veterans, including those with PTSD. This initiative strengthens the clinical narrative for COMP360 and expands its data set within a high-need population, though investors also face ongoing concerns about dilution risk due to rising net losses. The article highlights that while the VA trial is a positive clinical development, the company's financial situation and a recently filed shelf registration suggest potential future equity or debt issuance.", "date_published": "2026-08-13T09:42:34+00:00", "authors": [{"name": "Simply Wall Street"}], "tags": ["Earnings", "CMPS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "CMPS", "name": "Compass Pathways\u00a0Plc", "sentiment_url": "https://sharemaestro.com/sentiment/cbaf0ba4-9a5f-4624-83a0-ceb9d0edb90e/"}]}}, {"id": "source:278a885c0df52cee6559c38d64e0ac440110780139ded7065406eafd9fd3787a", "url": "https://www.marketbeat.com/instant-alerts/filing-royal-bank-of-canada-purchases-179418-shares-of-fresenius-medical-care-ag-co-kgaa-fms-2026-08-13", "external_url": "https://www.marketbeat.com/instant-alerts/filing-royal-bank-of-canada-purchases-179418-shares-of-fresenius-medical-care-ag-co-kgaa-fms-2026-08-13", "title": "Royal Bank of Canada Purchases 179,418 Shares of Fresenius Medical Care AG & Co. KGaA $FMS", "content_text": "Royal Bank of Canada significantly increased its stake in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) by 479.2% in the first quarter, acquiring 179,418 additional shares. This brings their total holdings to 216,861 shares, valued at approximately $4.9 million. Despite the substantial purchase, analyst sentiment remains cautious, with an average \"Reduce\" rating and a price target of $23.57.", "date_published": "2026-08-13T09:39:54+00:00", "authors": [{"name": "MarketBeat"}], "tags": ["Earnings", "FMS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "FMS", "name": "Fresenius Medical Care Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/27e2f7b1-dd48-4aa0-9487-0537c505e5d1/"}]}}, {"id": "source:16d7c704c2d782007b0b24868c5d889a41fd10b98909e4b0896b7ebb9a737474", "url": "https://www.mcknightsseniorliving.com/news/guardian-pharmacy-services-opens-first-location-in-kentucky", "external_url": "https://www.mcknightsseniorliving.com/news/guardian-pharmacy-services-opens-first-location-in-kentucky", "title": "Guardian Pharmacy Services opens first location in Kentucky", "content_text": "Guardian Pharmacy Services has opened its first Kentucky location, Guardian Pharmacy of Kentucky, in Lexington. This new long-term care pharmacy will serve residents in various care settings across the state. The expansion aims to meet increasing demand for LTC pharmacy services in Kentucky, combining local leadership with centralized corporate support.", "date_published": "2026-08-13T09:12:29+00:00", "authors": [{"name": "McKnight's Senior Living"}], "tags": ["Macro sensitivity", "GRDN"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "GRDN", "name": "Guardian Pharmacy Services, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/ab6794dc-f722-48cf-b38a-1ff4be20db65/"}]}}, {"id": "source:cbd7433bc3f906503156aca90fcc642d4021879cc025f1c009fd889e4429837d", "url": "https://www.marketbeat.com/instant-alerts/filing-sei-investments-co-acquires-34925-shares-of-amn-healthcare-services-inc-amn-2026-08-13", "external_url": "https://www.marketbeat.com/instant-alerts/filing-sei-investments-co-acquires-34925-shares-of-amn-healthcare-services-inc-amn-2026-08-13", "title": "Sei Investments Co. Acquires 34,925 Shares of AMN Healthcare Services Inc $AMN", "content_text": "Sei Investments Co. significantly increased its stake in AMN Healthcare Services Inc. (NYSE:AMN) by 204.7% in the first quarter, purchasing an additional 34,925 shares. This move is part of a broader trend of institutional investors adjusting their positions in AMN Healthcare, with several firms either increasing or initiating new stakes. The article also notes AMN Healthcare's recent financial performance, insider trading activity, and updated analyst ratings.", "date_published": "2026-08-13T08:42:18+00:00", "authors": [{"name": "MarketBeat"}], "tags": ["Earnings", "AMN"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AMN", "name": "AMN Healthcare Services Inc", "sentiment_url": "https://sharemaestro.com/sentiment/42b6a61f-5fd4-42a5-8c96-f4bbe14ea8fc/"}]}}, {"id": "source:3617c757fd70fcf28126fbf66d3c7772bb05ebc22a5b3412776533b2084182b2", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPY1ZmX2lxVUMzeE5TNzlyM3RyVmQ5Q2plUW04QXNzWWg3ZmxzTXVJNWl0cndlRzR6T2l6bTN0Qmt0d3FMTEFRU3JwX1pWamNJSmVZclo5TEFMZmdCU0RKbjRHOHBObEsxSTlKcUs1bjZmekZQbkswWHcyb1NhQTY3dG1jUVFaalVUVkhSMnBuZHZQZEpqWDlWU1dQaEo1Wi1nWEhwVjlqMXVuS1FNWDIzdWhSUjl1U2VDOGM3a3dwLVpEcllxek9FRkZxUQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPY1ZmX2lxVUMzeE5TNzlyM3RyVmQ5Q2plUW04QXNzWWg3ZmxzTXVJNWl0cndlRzR6T2l6bTN0Qmt0d3FMTEFRU3JwX1pWamNJSmVZclo5TEFMZmdCU0RKbjRHOHBObEsxSTlKcUs1bjZmekZQbkswWHcyb1NhQTY3dG1jUVFaalVUVkhSMnBuZHZQZEpqWDlWU1dQaEo1Wi1nWEhwVjlqMXVuS1FNWDIzdWhSUjl1U2VDOGM3a3dwLVpEcllxek9FRkZxUQ?oc=5", "title": "5 Must-Read Analyst Questions From Astrana Health\u2019s Q2 Earnings Call", "content_text": "5 Must-Read Analyst Questions From Astrana Health\u2019s Q2 Earnings Call", "date_published": "2026-08-13T08:36:29+00:00", "authors": [{"name": "StockStory"}], "tags": ["Earnings", "ASTH"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ASTH", "name": "Astrana Health Inc", "sentiment_url": "https://sharemaestro.com/sentiment/7b1b50ef-1773-4669-abcb-2c7b392afed3/"}]}}, {"id": "source:92346b7114c369cefa7bf0b0da71f9cbd962e5a7aaa02e1e2732365cb1e8a08c", "url": "https://www.tradingview.com/news/tradingview:8c5a383283c30:0-pediatrix-medical-group-inc-stock-12-month-price-target-cut-to-26-implies-2-downside", "external_url": "https://www.tradingview.com/news/tradingview:8c5a383283c30:0-pediatrix-medical-group-inc-stock-12-month-price-target-cut-to-26-implies-2-downside", "title": "Pediatrix Medical Group, Inc. Stock 12\u2011Month Price Target Cut to $26, Implies 2% Downside", "content_text": "The average 12-month price target for Pediatrix Medical Group, Inc. (MD) stock has been lowered from $26.17 to $26 by 5 analysts, with a range of $21 to $28 per share. This new target suggests a potential 2% downside from the August 12 closing price. The consensus rating among 6 covering analysts has shifted to \"Hold,\" with one \"Buy\" and five \"Hold\" recommendations.", "date_published": "2026-08-13T07:13:06+00:00", "authors": [{"name": "TradingView"}], "tags": ["Market update", "MD"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "MD", "name": "Mednax Inc", "sentiment_url": "https://sharemaestro.com/sentiment/dde769e7-6501-4809-8099-0e9ba18c0c14/"}]}}, {"id": "source:4075f1d0ae41105101f080759b3c978e04c54cdd4849f6bffa98855972db069b", "url": "https://finance.yahoo.com/healthcare/articles/tenet-golden-cross-higher-eps-061136768.html", "external_url": "https://finance.yahoo.com/healthcare/articles/tenet-golden-cross-higher-eps-061136768.html", "title": "Is Tenet\u2019s Golden Cross, Higher EPS Guidance and Ambulatory Push Altering The Investment Case For Tenet Healthcare (THC)?", "content_text": "Recently, Tenet Healthcare reported a bullish technical \"golden cross\" alongside higher earnings estimates, while management raised its 2026 adjusted EPS guidance and outlined further investment in its ambulatory care platform. The company's emphasis on higher-acuity services, expanding outpatient capabilities, and strengthened earnings outlook has reinforced investor attention on its evolving business mix and growth priorities. Against this backdrop, we'll explore how Tenet Healthcare's upgraded earnings guidance and ambulatory care expansion shape its broader investment narrative. Uncover th", "date_published": "2026-08-13T06:11:36+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "THC"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "THC", "name": "Tenet Healthcare Corporation", "sentiment_url": "https://sharemaestro.com/sentiment/b546ed3d-f2c6-4bb8-8e4d-94066f779bac/"}]}}, {"id": "source:b08b704424328b54d89b2a99a50e1bf1f54c50e73280ee02109851d94c5efe43", "url": "https://www.tradingview.com/news/stockstory:c1180ec2f094b:0-5-revealing-analyst-questions-from-amn-healthcare-services-s-q2-earnings-call", "external_url": "https://www.tradingview.com/news/stockstory:c1180ec2f094b:0-5-revealing-analyst-questions-from-amn-healthcare-services-s-q2-earnings-call", "title": "5 Revealing Analyst Questions From AMN Healthcare Services\u2019s Q2 Earnings Call", "content_text": "AMN Healthcare Services reported Q2 results that surpassed analyst expectations, driven by strong demand in its Nurse and Allied Solutions segment and effective execution. The article highlights five key analyst questions from the earnings call, covering topics like contingent labor trends, margin assumptions, bill rates, M&A strategy, and reasons for hospital hiring slowdowns. The company's future outlook will focus on sustained growth, technology enhancements, and strategic acquisitions.", "date_published": "2026-08-13T05:42:18+00:00", "authors": [{"name": "TradingView"}], "tags": ["Deals and strategy", "AMN"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AMN", "name": "AMN Healthcare Services Inc", "sentiment_url": "https://sharemaestro.com/sentiment/42b6a61f-5fd4-42a5-8c96-f4bbe14ea8fc/"}]}}, {"id": "source:fc73b8d076e74c2e57b19e087a20718a14289f44b8fdf572f3aaff8c357c7a8f", "url": "https://www.nasdaq.com/articles/usph-usph-q2-2026-earnings-call-transcript", "external_url": "https://www.nasdaq.com/articles/usph-usph-q2-2026-earnings-call-transcript", "title": "USPH (USPH) Q2 2026 Earnings Call Transcript", "content_text": "Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 10:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Christopher ReadingPresident and Chief Operating Officer, East - Eric WilliamsInterim Chief Financial Officer and Senior Vice President of Finance and Accounting - Jason CurtisExecutive Vice President and General Counsel - Rick BinsteinChief Operating Officer, West - Graham ReeveVice President of Accounting and Controller - Kate Venturina TAKEAWAYS Total Net Revenue -- $214.1 million, an 8.5% increase from the prior year quarter.Physical Therapy Net Revenue -- $182.4 million, growing 8.4% due to visit strength and record net rates.Industrial Injury Prevention Revenue -- $31.7 million, a 9.1% increase reflecting organic growth and the impact of a January 2026 acquisition.Net Income Attributable to Shareholders -- $9.9 million, down from $12.4 million in the year-ago period due to higher employee health costs and front-loaded hiring expenses.Adjusted EBITDA -- $27.0 million, remaining relatively flat compared to $26.9 million in the second quarter of 2025.Patient Visits -- 1,661,694, a 6.6% increase inclusive of new hospital affiliation clinics.Visits Per Clinic Per Day -- 33.5, representing an all-time record for the company.Net Revenue Per Patient Visit -- $107.59, an increase of $2.26 from the prior year quarter.Hospital Affiliation Revenue -- $5.6 million, contributed during the initial phases of the hospital alliance rollout.Physical Therapy Gross Margin -- 19.5%, pressured by a 100 basis point impact from unfavorable employee health benefit costs.Self-Insured Health Care Costs -- $3.2 million higher year over year, driven by a small number of significant employee claims compared to a lighter-than-normal 2025 experience.Medicare Revenue Per Visit -- Increased 3.7%, reflecting a net 1.1% realized rate increase after accounting for Medicare Advantage mix.Commercial and Workers' Comp Rates -- Increased 1.2% and 2.0% respectively, contributing to the record overall net rate.Corporate Expense -- 8.4% of revenue on an adjusted basis, compared to 8.7% in the second quarter of 2025.M&A Activity -- $16.4 million spent to acquire a 67% equity interest in a 12-clinic physical therapy practice with $12 million in annual revenue.Total 2026 Acquisition Spending -- $37.6 million year to date, covering three acquisitions with combined annualized revenue of approximately $27 million.Share Repurchases -- 306,256 shares repurchased for $19.2 million at an average price of $62.80 during the quarter.Liquidity -- $229 million available on a $450 million credit facility, which includes a $125 million accordion feature.Full Year 2026 Guidance -- Management reaffirmed adjusted EBITDA targets of $102 million to $106 million.Medicare Guidance Impact -- $2.5 million expected revenue lift for the full year 2026, equating to a $0.35 per visit rate increase. Need a quote from a Motley Fool analyst? Email pr@fool.com RISKS Reading stated, \"Due to a small number of very significant claims across our employee base, we're running well ahead of our usual cost and our claims experience this year,\" noting this healthcare cost volatility as a primary headwind to margins.Reading reported that the Industrial Injury Prevention segment lost a contract with a Japanese automobile manufacturer after the client changed its healthcare decision-making hierarchy, contributing to a temporary organic growth slowdown.Williams noted that one injury prevention business had \"a number of open positions that have been taking longer to fill,\" preventing the segment from executing against its revenue pipeline. SUMMARY Management reported record operational volume and net rates during the second quarter, although bottom-line results were tempered by volatile employee healthcare costs and strategic front-loading of clinical hires. The company integrated 31 existing clinics into new hospital affiliations with 39 additional locations scheduled for transiti", "date_published": "2026-08-13T05:13:38+00:00", "authors": [{"name": "nasdaq.com"}], "tags": ["Market update", "USPH"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "USPH", "name": "U.S. Physical Therapy, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/2aea3c2c-c544-4cfb-b433-edc5ff2de19e/"}]}}, {"id": "source:377e59c10c9756833cf7e3a49a63e4fbc9d314d26777cf94753ed729833fe0c7", "url": "https://finance.yahoo.com/markets/stocks/articles/top-5-analyst-questions-davita-045300692.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/top-5-analyst-questions-davita-045300692.html", "title": "The Top 5 Analyst Questions From DaVita\u2019s Q2 Earnings Call", "content_text": "The Top 5 Analyst Questions From DaVita's Q2 Earnings Call DaVita's second quarter results surpassed Wall Street's revenue and adjusted profit expectations, but the market response was notably negative. Management attributed this to a mix of operational and industry-specific challenges, including flat treatment volumes and sequential declines in revenue per treatment, primarily due to a less favorable commercial mix and reduced revenue from phosphate binders. CEO Javier Rodriguez emphasized, \"Our growth is mainly performance clinical\u2014that expands life, and therefore, you get the volume treatme", "date_published": "2026-08-13T04:53:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "DVA"], "_sharemaestro": {"country": "United States", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "DVA", "name": "DaVita HealthCare Partners Inc", "sentiment_url": "https://sharemaestro.com/sentiment/bc454156-cf6a-4330-8e23-013562fc8248/"}]}}, {"id": "source:522c27e52b41e416988a24586cbfef7f366080c356e0c2405375adef5a00fcb2", "url": "https://www.theglobeandmail.com/investing/markets/stocks/SGRY/pressreleases/3825138/outpatient-specialty-care-stocks-q2-highlights-surgery-partners-nasdaqsgry", "external_url": "https://www.theglobeandmail.com/investing/markets/stocks/SGRY/pressreleases/3825138/outpatient-specialty-care-stocks-q2-highlights-surgery-partners-nasdaqsgry", "title": "Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY)", "content_text": "The outpatient and specialty care industry showed strong Q2 results, with revenues beating analysts' consensus estimates. Surgery Partners (NASDAQ:SGRY) reported a 2.7% year-on-year revenue increase to $848.9 million, exceeding expectations, but delivered the slowest revenue growth and weakest full-year guidance among its peers. In contrast, LifeStance Health Group (NASDAQ:LFST) achieved the highest analyst estimate beat and fastest revenue growth, with revenues up 26.1% to $435.4 million.", "date_published": "2026-08-13T03:41:42+00:00", "authors": [{"name": "The Globe and Mail"}], "tags": ["Earnings", "SGRY"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SGRY", "name": "Surgery Partners Inc", "sentiment_url": "https://sharemaestro.com/sentiment/f22c9666-cdb5-4ff3-9539-3ca4f4fe7e65/"}]}}]}